A Toender1, T Munk-Olsen2, M Vestergaard3, J T Larsen4, N P Suppli5, S O Dalton6, P Vedsted7, M Nordentoft8, P B Mortensen9, T M Laursen10. 1. National Centre for Register-Based Research, Aarhus BSS, Aarhus University, Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; Centre for Integrated Register-based Research (CIRRAU), Aarhus University, Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark. Electronic address: toender@econ.au.dk. 2. National Centre for Register-Based Research, Aarhus BSS, Aarhus University, Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark. Electronic address: tmo@econ.au.dk. 3. Research Unit for General Practice, Department of Public Health, Aarhus University, Department of Public Health, Bartholins Allé 2, Building 1260, 8000 Aarhus C, Denmark. Electronic address: mv@ph.au.dk. 4. National Centre for Register-Based Research, Aarhus BSS, Aarhus University, Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark. Electronic address: jtl@econ.au.dk. 5. The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; Survivorship, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 København Ø, Denmark; Mental Health Centre Copenhagen, Faculty of Health and Medical Science, University of Copenhagen, Bispebjerg Bakke 23A, 2400 København, NV, Denmark. Electronic address: suppli@cancer.dk. 6. Survivorship, Danish Cancer Society Research Center, Strandboulevarden 49, 2100 København Ø, Denmark. Electronic address: sanne@cancer.dk. 7. Research Unit for General Practice, Department of Public Health, Aarhus University, Department of Public Health, Bartholins Allé 2, Building 1260, 8000 Aarhus C, Denmark. Electronic address: p.vedsted@ph.au.dk. 8. The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; Mental Health Centre Copenhagen, Faculty of Health and Medical Science, University of Copenhagen, Bispebjerg Bakke 23A, 2400 København, NV, Denmark. Electronic address: d198080@dadlnet.dk. 9. National Centre for Register-Based Research, Aarhus BSS, Aarhus University, Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark. Electronic address: pbm@econ.au.dk. 10. National Centre for Register-Based Research, Aarhus BSS, Aarhus University, Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark; The Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Fuglesangs Allé 26, Building R, 8210 Aarhus V, Denmark. Electronic address: tml@econ.au.dk.
Abstract
BACKGROUND: Excess mortality in individuals with severe mental illness (SMI) is often explained by physical comorbidity and suboptimal healthcare. Cancer is a prevalent cause of death, and tumour stage at diagnosis is a strong predictor of mortality. We aimed to study cancer incidence, disease stage at diagnosis and subsequent mortality in individuals with SMI compared to individuals without SMI. METHODS: The entire Danish population was followed in 1978-2013 using nationwide registries. Cancer incidence and subsequent mortality stratified by disease stage were compared in individuals with and without SMI. Cox regression was used to estimate incidence rate ratios (IRR) and mortality rate ratios (MRR). Cancer was examined overall and grouped by major aetiological factors. RESULTS: The overall cancer incidence rate was lower in males with SMI than in males without SMI; IRR = 0.89 (95% CI: 0.85-0.94), but rates were similar in females with SMI and without SMI; IRR = 1.03 (95% CI: 0.99-1.07). The overall mortality rate was higher in individuals with SMI than those without; MRR = 1.56 (95% CI: 1.48-1.64) for males and MRR = 1.49 (95% CI: 1.43-1.56) for females. Incidence rates and mortality rates showed similar estimates when stratified by tumour stage and aetiology. CONCLUSIONS: We found lower cancer incidence in males with SMI compared to males without SMI and similar incidence in the two groups of women. Higher subsequent mortality was found in both sexes with SMI. The excess mortality was not explained by more advanced stages of cancer; future studies should evaluate the effect of cancer treatment and rehabilitation.
BACKGROUND: Excess mortality in individuals with severe mental illness (SMI) is often explained by physical comorbidity and suboptimal healthcare. Cancer is a prevalent cause of death, and tumour stage at diagnosis is a strong predictor of mortality. We aimed to study cancer incidence, disease stage at diagnosis and subsequent mortality in individuals with SMI compared to individuals without SMI. METHODS: The entire Danish population was followed in 1978-2013 using nationwide registries. Cancer incidence and subsequent mortality stratified by disease stage were compared in individuals with and without SMI. Cox regression was used to estimate incidence rate ratios (IRR) and mortality rate ratios (MRR). Cancer was examined overall and grouped by major aetiological factors. RESULTS: The overall cancer incidence rate was lower in males with SMI than in males without SMI; IRR = 0.89 (95% CI: 0.85-0.94), but rates were similar in females with SMI and without SMI; IRR = 1.03 (95% CI: 0.99-1.07). The overall mortality rate was higher in individuals with SMI than those without; MRR = 1.56 (95% CI: 1.48-1.64) for males and MRR = 1.49 (95% CI: 1.43-1.56) for females. Incidence rates and mortality rates showed similar estimates when stratified by tumour stage and aetiology. CONCLUSIONS: We found lower cancer incidence in males with SMI compared to males without SMI and similar incidence in the two groups of women. Higher subsequent mortality was found in both sexes with SMI. The excess mortality was not explained by more advanced stages of cancer; future studies should evaluate the effect of cancer treatment and rehabilitation.
Authors: Natalie C Momen; Oleguer Plana-Ripoll; Esben Agerbo; Michael E Benros; Anders D Børglum; Maria K Christensen; Søren Dalsgaard; Louisa Degenhardt; Peter de Jonge; Jean-Christophe P G Debost; Morten Fenger-Grøn; Jane M Gunn; Kim M Iburg; Lars V Kessing; Ronald C Kessler; Thomas M Laursen; Carmen C W Lim; Ole Mors; Preben B Mortensen; Katherine L Musliner; Merete Nordentoft; Carsten B Pedersen; Liselotte V Petersen; Anette R Ribe; Annelieke M Roest; Sukanta Saha; Andrew J Schork; Kate M Scott; Carson Sievert; Holger J Sørensen; Terry J Stedman; Mogens Vestergaard; Bjarni Vilhjalmsson; Thomas Werge; Nanna Weye; Harvey A Whiteford; Anders Prior; John J McGrath Journal: N Engl J Med Date: 2020-04-30 Impact factor: 91.245
Authors: Line Flytkjær Virgilsen; Peter Vedsted; Alina Zalounina Falborg; Anette Fischer Pedersen; Anders Prior; Henry Jensen Journal: BMC Cancer Date: 2022-04-29 Impact factor: 4.638
Authors: Melinda M Protani; Susan J Jordan; Bradley J Kendall; Dan Siskind; David Lawrence; Grant Sara; Lisa Brophy; Steve Kisely Journal: BMJ Open Date: 2021-06-08 Impact factor: 2.692